Jeanette Lundin

Jeanette Lundin

UNVERIFIED PROFILE

Are you Jeanette Lundin?   Register this Author

Register author
Jeanette Lundin

Jeanette Lundin

Publications by authors named "Jeanette Lundin"

Are you Jeanette Lundin?   Register this Author

28Publications

453Reads

34Profile Views

Calcein release assay as a method for monitoring serum complement activity during monoclonal antibody therapy in patients with B-cell malignancies.

J Immunol Methods 2020 Jan 17;476:112675. Epub 2019 Oct 17.

Department of Medical Biotechnology, Intercollegiate Faculty of Biotechnology, University of Gdańsk and Medical University of Gdańsk, Dębinki 1 street, 80-211 Gdańsk, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jim.2019.112675DOI Listing
January 2020

The tyrosine kinase receptor ROR1 is constitutively phosphorylated in chronic lymphocytic leukemia (CLL) cells.

PLoS One 2013 24;8(10):e78339. Epub 2013 Oct 24.

Department of Oncology-Pathology, Immune and Gene therapy Lab, Cancer Center Karolinska (CCK), Karolinska University Hospital Solna and Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0078339PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813472PMC
February 2015

Outcomes of patients with fludarabine-refractory chronic lymphocytic leukemia: a population-based study from a well-defined geographic region.

Leuk Lymphoma 2014 Aug 4;55(8):1774-80. Epub 2014 Feb 4.

Departments of Hematology and Oncology, Karolinska University Hospital , Stockholm , Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2013.827786DOI Listing
August 2014

Tumor burden status evaluated by computed tomography scan is of prognostic importance in patients with chronic lymphocytic leukemia.

Med Oncol 2010 Sep 25;27(3):820-5. Epub 2009 Aug 25.

Department of Hematology, Karolinska University Hospital Solna, 171 76, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-009-9292-yDOI Listing
September 2010

Alemtuzumab to treat refractory autoimmune hemolytic anemia or thrombocytopenia in chronic lymphocytic leukemia.

Curr Hematol Malig Rep 2009 Jan;4(1):47-53

Department of Hematology, Karolinska University Hospital Solna, SE-171 76, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11899-009-0007-4DOI Listing
January 2009

Performance of calibration standards for antigen quantitation with flow cytometry in chronic lymphocytic leukemia.

Cytometry B Clin Cytom 2007 Nov;72(6):450-7

Department of Oncology (Radiumhemmet), Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cyto.b.20359DOI Listing
November 2007

Reconstitution of the T-cell repertoire following treatment with alemtuzumab (anti-CD52 monoclonal antibody) in patients with B-cell chronic lymphocytic leukaemia.

Br J Haematol 2006 Nov 22;135(4):475-85. Epub 2006 Sep 22.

Immune and Gene Therapy Laboratory, Department of Oncology and Pathology, Cancer Centre Karolinska (CCK), Karolinska Institutet, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2006.06324.xDOI Listing
November 2006

Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia.

Med Oncol 2006 ;23(1):137-9

Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1385/MO:23:3
Publisher Site
http://dx.doi.org/10.1385/MO:23:3DOI Listing
June 2006

Strategies in the management of alemtuzumab-related side effects.

Semin Oncol 2006 Apr;33(2 Suppl 5):S29-35

Department of Oncology and Hematology, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2006.01.027DOI Listing
April 2006

Advances in the use of monoclonal antibodies in the therapy of chronic lymphocytic leukemia.

Semin Hematol 2004 Jul;41(3):234-45

Departments of Hematology/Oncology, Karolinska University Hospital, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminhematol.2004.05.005DOI Listing
July 2004

Therapy for mycosis fungoides.

Curr Treat Options Oncol 2004 Jun;5(3):203-14

Department of Hematology and Oncology, Karolinska Hospital, SE-171 76 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11864-004-0012-8DOI Listing
June 2004